Deine erste Kategorie » ng lifecycle management strategi

Advanced Technologies| Competitor Landscape: Systemic Sclerosis (Scleroderma)
by chhidami12 · January 14 Cheap Tre Boston Jersey , 2019


Researchmoz added Most up-to-date research on “Competitor Landscape: Systemic Sclerosis (Scleroderma)” to its huge collection of research reports.


Competitor Landscape: Systemic Sclerosis (Scleroderma)


Summary


Sociable Pharmas Treatment Landscape contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current & potential future product positioning Cheap Ricky Seals-Jones Jersey , and forecast approval dates (by quarter) for candidates in Phase II development, or higher –
– Executive Summary: Contains analysis of key market events that have occurred during the previous month and which have impacted Sociable Pharmas view of the disease landscape
– Landscape Updates: Order of Entry analysis Cheap Gabe Holmes Jersey , detailing timeline forecasts for each drug in Phase II development or higher; Timeline forecasts for each approved products lifecycle management initiatives; Market Entry & Direction of Travel positioning analysis for pipeline & currently approved therapies
– Pipeline Landscape: An overview of pipeline candidates, containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019
– Approved Product Landscape: An overview of pipeline candidates Cheap Justin Pugh Jersey , containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019


To Get Sample Copy of Report visit @ ;repid=1978212


Key Highlights


– New Phase I study to evaluate drug-drug interactions could allow nintedanib to be administered concomitantly with relevant birth-control pills, potentially increasing the eligible patient population for nintedanib
– Corbus Pharmaceuticals continues to present data for lenabasum at rheumatology conferences Cheap Markus Golden Jersey , as the company attempts to increase awareness of its late stage pipeline candidate, which could facilitate patient recruitment to its ongoing Phase III RESOLVE-1 trial
– Completion of recruitment for SAR-156597’s Phase II trial was confirmed ahead of its expected primary completion in Q4 2018.


Scope


– The briefing is based on Sociable Pharmas analysis of clinical trial data from company announcements (press releases Cheap D.J. Humphries Jersey , earnings calls) and clinical trial databases ( )
– Sociable Pharma applies disease & drug specific assumptions in order to forecast US & EU approvals for drugs in Phase II development, or higher – these are outlined in the report Appendix
– Forecasts are presented in pipeline forecast figures & detailed tables
– Market Entry & Direction of Travel positioning analysis for pipeline & currently approved therapies is also provided.


Reasons to buy


– Provides details on forecast US & EU approvals for pipeline drugs in Phase II development or higher
– Includes potential positioning strategies that companies may adopt for their novel assets once they are approved & launched in the market
– Reviews ongoing lifecycle management strategies for existing players in the market
– A detailed methodology allows you to understand the forecast assumptions made Cheap Robert Nkemdiche Jersey , enabling cross comparison with your own internal forecasts.


Get Complete TOC With Tables and Figures @